3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Pancreatic Neoplasms
90
Breast Neoplasms
87
Carcinoma, Non-Small-Cell Lung
33
Triple Negative Breast Neoplasms
22
Squamous Cell Carcinoma of Head and Neck
19
Neoplasms
18
Neoplasm Metastasis
18
Ovarian Neoplasms
17
Stomach Neoplasms
15
Lung Neoplasms
13
Head and Neck Neoplasms
11
Esophageal Squamous Cell Carcinoma
10
Esophageal Neoplasms
10
Cholangiocarcinoma
10
Recurrence
9
Melanoma
8
Small Cell Lung Carcinoma
7
Sarcoma
7
Pancreatic Adenocarcinoma
7
Inflammatory Breast Neoplasms
7
Breast Neoplasms, Male
7
Adenocarcinoma
7
Prostatic Neoplasms
6
Fallopian Tube Neoplasms
6
Urinary Bladder Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Biliary Tract Neoplasms
5
Uterine Cervical Neoplasms
4
Gallbladder Neoplasms
4
Carcinoma, Ductal, Breast
4
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
9
Papillomavirus Vaccines
8
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
8
Surveys and Questionnaires
6
Educational Status
6
Blood Specimen Collection
5
Vaginal Smears
4
Radiotherapy, Intensity-Modulated
4
Methods
4
Human Papillomavirus DNA Tests
4
Early Intervention, Educational
4
Cisplatin
4
Carboplatin
4
Patient Navigation
3
Mass Screening
3
Taxes
2
Standard of Care
2
Radiation
2
Practice Guidelines as Topic
2
Papanicolaou Test
2
Paclitaxel
2
Motivational Interviewing
2
Interviews as Topic
2
Electrocoagulation
2
Docetaxel
2
Cytological Techniques
2
Cryotherapy
2
Colposcopy
2
utomilumab
1
toripalimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Papillomavirus Infections
×
Albumin-Bound Paclitaxel
×
Clear all
NCT02258659
2024-09-24
OPTIMA
University of Chicago
Phase 2
Completed
62 enrolled
13 charts